Herbalife (HLF) Misses Q2 EPS by 2c; Guides Q3 EPS Below Views
Get Alerts HLF Hot Sheet
Revenue Growth %: -4.6%
Financial Fact:
Income taxes: 41.7M
Today's EPS Names:
BFRI, HCTI, IMPM, More
Join SI Premium – FREE
(Updated - July 28, 2014 4:44 PM EDT)
Herbalife (NYSE: HLF) reported Q2 EPS of $1.55, $0.02 worse than the analyst estimate of $1.57. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.35 billion.
Global volume growth was 5 percent in Q2.
“Herbalife has once again delivered strong results in sales and profitability while demonstrating our continued ability to enhance our earnings per share,” said Michael Johnson, Herbalife’s chairman and CEO. “Our performance is a testament to the enthusiasm our millions of consumers and members have for our products. Additionally, our independent members are successfully executing numerous growth strategies to further develop customer loyalty and encourage individuals across our network to lead healthier, nutritious lives. Our members are proud to be a part of a solution to global public health issues and we value the integral role they play in Herbalife’s mission.”
Sees Q3 EPS of $1.49 to $1.53, with the consensus at $1.62. Sees net sales up 9 to 11 percent.
Herbalife sees FY2014 EPS of $6.17 to $6.32, from prior expectations of $6.10 to $6.30 and the consensus of $6.30. Expects sales growth of 8.5 to 10.5 percent, from 10 to 12 percent with the company's prior quarterly release.
For earnings history and earnings-related data on Herbalife (HLF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. Steel (X) slightly down as Q1 guidance fails to meet expectations
- Alpine Immune Sciences (ALPN) Reports FY Loss of $0.64
- Peraso Inc. (PRSO) Misses Q4 EPS by 844c
Create E-mail Alert Related Categories
Earnings, Guidance, Hedge Funds, Hot Corp. News, Hot Earnings, Hot Guidance, Hot List, Management Comments, Trader TalkRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!